Companies: 10,795·Total market cap: $144.5T
Crescita Therapeutics Inc.

Crescita Therapeutics Inc.

CTX.TOTSXHealthcare● Active
$0.79
+$0.00(+0.00%)
Market Cap$14705011
P/E Ratio
52W High$0.79
52W Low$0.4
Overview

Crescita Therapeutics Inc. (CTX.TO) · Balance Sheet

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · CTX.TO · as of 2026-06-10

Financial statements

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$8.58M$9.27M$9.38M$8.24M$11.33M
Net Receivables$2.11M$1.72M$2.77M$6.24M$3.75M
Inventory$4.72M$4.05M$6.13M$5.65M$4.39M
Total Current Assets$15.72M$15.30M$18.49M$20.52M$20.09M
PP&E Net$1.79M$2.42M$1.85M$2.31M$2.58M
Goodwill$0.00M$0.00M$0.00M$0.00M$0.00M
Intangible Assets$1.46M$1.74M$1.99M$2.87M$3.74M
Total Assets$20.33M$21.78M$24.60M$28.48M$28.92M
Liabilities
Short-Term Debt$0.33M$0.47M$0.00M$0.00M$0.98M
Accounts Payable$4.33M$5.00M$4.33M$5.60M$5.33M
Total Current Liabilities$4.72M$5.51M$4.86M$6.06M$6.72M
Long-Term Debt$0.00M$0.00M$0.00M$0.00M$0.00M
Total Liabilities$4.75M$5.95M$5.78M$7.39M$8.40M
Stockholders Equity
Retained Earnings($45.44M)($45.35M)($42.60M)($40.61M)($41.48M)
Total Stockholders Equity$15.58M$15.83M$18.82M$21.10M$20.53M
Total Liab & Equity(computed)$20.33M$21.78M$24.60M$28.48M$28.92M
Debt Summary
Total Debt$0.33M$0.83M$1.25M$1.61M$2.87M
Net Debt($8.24M)($8.44M)($8.13M)($6.63M)($8.46M)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · CAD · M

Explore more Crescita Therapeutics Inc. data

About Crescita Therapeutics Inc. (CTX.TO) Balance Sheet

Crescita Therapeutics Inc. (CTX.TO) balance sheet shows total assets of $0.02B with cash of $0.01B. Total liabilities are $0.00B, total debt $0.00B, and stockholders equity $0.02B.

Frequently asked questions

CTX.TO · 4 questions

Crescita Therapeutics Inc. has total debt of $0.00B with net debt of ($0.01B).

CTX.TO total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10